Skip to main content
. 2021 Jul 23;7(8):e735. doi: 10.1097/TXD.0000000000001192

TABLE 1.

Recipient, donor, and operative factors in patients undergoing split liver transplantation with and without interposition graft

Arterial reconstruction with interposition graft (n = 46) Arterial reconstruction without interposition graft (n = 105) P
Recipient factors
 Age at transplant (mean ± S) 51.5 ± 11.2 51.4 ± 10.6 0.983
 Sex, male (%) 27/46 (58.7%) 68/105 (64.8%) 0.478
 BMI, median (IQR) 25.3 (5.2) 25.0 (5.1) 0.477
 MELD score, mean ± SD 17 ± 8 19 ± 8 0.063
 High MELD score (≥15) 24/44 (54.5%) 71/98 (72.4%) 0.036*
 Indication for transplant Alcohol 4/46 (8.7%) 13/105 (12.4%) 0.183
Hepatitis B or C 15/46 (32.6%) 25/105 (23.8%)
HCC 14/46 (30.4%) 17/105 (16.2%)
PSC 2/46 (4.3%) 17/105 (16.2%)
NASH 1/46 (2.2%) 4/105 (3.8%)
PBC 0/46 (0%) 7/105 (6.7%)
Other 10/46 (21.7%) 22/105 (21.0%)
 Retransplant 2/46 (4.3%) 1/104 (1.0%) 0.220
Donor factors
 Age, mean ± SD 30.4 ± 10.2 33.0 ± 11.5 0.174
 Sex (male, %) 24/46 (52.2%) 66/105 (62.9%) 0.218
 BMI, median (IQR) 24.7 (4.9) 23.7 (5.0) 0.118
 Cause of death Trauma 18/46 (39.1%) 39/105 (37.1%) 0.913
Cerebrovascular event 14/46 (30.4%) 41/105 (39.0%)
Cardiac arrest 1/35 (2.2%) 2/105 (1.9%)
Respiratory hypoxia 10/46 (21.7%) 17/105 (16.2%)
Other 3/46 (6.5%) 5/105 (4.8%)
 Donor risk index, median (IQR) 1.76 (0.43) 1.76 (0.38) 0.736
 Donor recipient weight ratio, median (IQR) 0.97 (0.30) 1.07 (0.37) 0.099
Operative factors
 Urgency of transplant 1—ICU 3/46 (6.5%) 5/105 (4.8%) 0.875
2—hospital bound 8/46 (17.4%) 14/105 (13.3%)
3—occasional inpatient 8/46 (17.4%) 19/105 (18.1%)
4—at home 27/46 (58.7%) 67/105 (63.8%)
 Cold ischemia time (min), median (IQR) 403 (201) 379 (206) 0.835
 Warm ischemia time (min), median (IQR) 47.5 (15) 45 (19) 0.292
 Packed cells, mean ± SD 6 ± 7 5 ± 6 0.364
 Operative time (min), mean ± SD 421 ± 217 356 ± 107 0.015*

*P <0.05.

BMI, body mass index; HCC, hepatocellular carcinoma; ICU, intensive care unit; IQR, interquartile range; MELD, model for end-stage liver disease; NASH, nonalcoholic steatohepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.